These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18458227)

  • 21. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype.
    Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A
    Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations].
    Funalot B; Magdelaine C; Sturtz F; Ouvrier R; Vallat JM
    Bull Acad Natl Med; 2009 Jan; 193(1):151-60; discussion 160-1. PubMed ID: 19718987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): report from India.
    Nalini A; Gayathri N; Yasha TC; Ravishankar S; Urtizberea A; Huehne K; Rautenstrauss B
    Eur J Med Genet; 2008; 51(5):426-35. PubMed ID: 18595793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.
    Burns TM; Phillips LH; Dimberg EL; Vaught BK; Klein CJ
    Neuromuscul Disord; 2006 May; 16(5):308-10. PubMed ID: 16616847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual splice defect in the mitofusin 2 gene (MFN2) is associated with degenerative axonopathy in Tyrolean Grey cattle.
    Drögemüller C; Reichart U; Seuberlich T; Oevermann A; Baumgartner M; Kühni Boghenbor K; Stoffel MH; Syring C; Meylan M; Müller S; Müller M; Gredler B; Sölkner J; Leeb T
    PLoS One; 2011 Apr; 6(4):e18931. PubMed ID: 21526202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
    Henneke M; Combes P; Diekmann S; Bertini E; Brockmann K; Burlina AP; Kaiser J; Ohlenbusch A; Plecko B; Rodriguez D; Boespflug-Tanguy O; Gärtner J
    Neurology; 2008 Mar; 70(10):748-54. PubMed ID: 18094336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.
    Namekawa M; Ribai P; Nelson I; Forlani S; Fellmann F; Goizet C; Depienne C; Stevanin G; Ruberg M; Dürr A; Brice A
    Neurology; 2006 Jan; 66(1):112-4. PubMed ID: 16401858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.
    Polke JM; Laurá M; Pareyson D; Taroni F; Milani M; Bergamin G; Gibbons VS; Houlden H; Chamley SC; Blake J; Devile C; Sandford R; Sweeney MG; Davis MB; Reilly MM
    Neurology; 2011 Jul; 77(2):168-73. PubMed ID: 21715711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).
    Koop O; Schirmacher A; Nelis E; Timmerman V; De Jonghe P; Ringelstein B; Rasic VM; Evrard P; Gärtner J; Claeys KG; Appenzeller S; Rautenstrauss B; Hühne K; Ramos-Arroyo MA; Wörle H; Moilanen JS; Hammans S; Kuhlenbäumer G
    Neuromuscul Disord; 2007 Aug; 17(8):624-30. PubMed ID: 17587580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses.
    Lv H; Wang L; Li W; Qiao X; Li Y; Wang Z; Yuan Y
    Clin Neuropathol; 2013; 32(1):16-23. PubMed ID: 22762946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal dominant spastic paraplegia with peripheral neuropathy maps to chr12q23-24.
    Schüle R; Bonin M; Dürr A; Forlani S; Sperfeld AD; Klimpe S; Mueller JC; Seibel A; van de Warrenburg BP; Bauer P; Schöls L
    Neurology; 2009 Jun; 72(22):1893-8. PubMed ID: 19357379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mitofusin 2 as a crucial peripheral nervous system protein and a common regulator of cell metabolism].
    Kawalec M; Kotruchow K; Kochański A; Zabłocka B
    Postepy Biochem; 2011; 57(2):215-21. PubMed ID: 21913423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations.
    Vallat JM; Ouvrier RA; Pollard JD; Magdelaine C; Zhu D; Nicholson GA; Grew S; Ryan MM; Funalot B
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1097-102. PubMed ID: 18957892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
    Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
    J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings.
    Banchs I; Casasnovas C; Montero J; Martínez-Matos JA; Volpini V
    Neuromuscul Disord; 2008 Dec; 18(12):974-8. PubMed ID: 18996695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.